Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies
Sijia Lü, Yibing Wang, Junli Liu
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 49, Iss. 4, pp. 269-278
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Georgia Xourafa, Melis Korbmacher, Michael Roden
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 1, pp. 27-49
Open Access | Times Cited: 98
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Stergios A. Pοlyzos
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 191-206
Open Access | Times Cited: 44
Exploring TNFR1: from discovery to targeted therapy development
Yingying Li, Ruiwei Ye, Haorui Dai, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation
Lingjie Yan, Tao Zhang, Kai Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota
Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13436-13436
Open Access | Times Cited: 41
Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease
Kalliopi Pafili, S. Kahl, Lucia Mastrototaro, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1504-1514
Open Access | Times Cited: 34
Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model
Seung‐Ju Hwang, Yujin Choi, Jing‐Hua Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116250-116250
Open Access | Times Cited: 6
TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice
Katharina Bürger, Finn Jung, Anja Baumann, et al.
Redox Biology (2023) Vol. 66, pp. 102870-102870
Open Access | Times Cited: 13
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
Xuan He, Yubing Li, Xinyu Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
TACE inhibition: a promising therapeutic intervention against AATF‐mediated steatohepatitis to hepatocarcinogenesis
Akshatha N. Srinivas, Diwakar Suresh, Prashant M. Vishwanath, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1940-1957
Open Access | Times Cited: 4
System failure: Systemic inflammation following spinal cord injury
Damon J. DiSabato, Christina M. Marion, Katherine A. Mifflin, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 1
Open Access | Times Cited: 10
Pine (Pinus koraiensis) Nut Oil Ameliorates Cholesterol Homeostasis and Inflammation via Modulating the miR-34a/122 Pathways in the Liver of Rats Fed a High-Cholesterol Diet
Yunji Lee, Mak-Soon Lee, Jumi Lee, et al.
Journal of Nutrition (2025)
Closed Access
The role of TNF in metabolic disorders and liver diseases
Chuze Xu, Sohaib Hasan Abdullah Ezzi, Xiaodi Zou, et al.
Cytokine (2025) Vol. 190, pp. 156933-156933
Closed Access
Molecular Mechanisms of Pyroptosis in Non-alcoholic Steatohepatitis and Feasible Diagnosis and Treatment Strategies
Dong Shang, Wanning Xu, Qing Zhao, et al.
Pharmacological Research (2025), pp. 107754-107754
Open Access
A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease
Guilherme Ribeiro Romualdo, Letícia Cardoso Valente, Gabriel P. Bacil, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
Nocellara Del Belice (Olea europaea L. Cultivar): Leaf Extract Concentrated in Phenolic Compounds and Its Anti-Inflammatory and Radical Scavenging Activity
Vincenzo Musolino, Roberta Macrì, Antonio Cardamone, et al.
Plants (2022) Vol. 12, Iss. 1, pp. 27-27
Open Access | Times Cited: 15
The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Yadi Miao, Ziyong Li, Juan Feng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6895-6895
Open Access | Times Cited: 3
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH
Daniela Gabbia, Marco Roverso, Ilaria Zanotto, et al.
Marine Drugs (2022) Vol. 20, Iss. 9, pp. 572-572
Open Access | Times Cited: 13
Network pharmacological analysis on the mechanism of Linggui Zhugan decoction for nonalcoholic fatty liver disease
Songlin Gao, Liuting Wei, Yan Qin, et al.
Medicine (2024) Vol. 103, Iss. 10, pp. e37281-e37281
Open Access | Times Cited: 2
Essential Oils for the Treatment and Management of Nonalcoholic Fatty Liver Disease (NAFLD)
Tae-Hwa Kim, Mohammad Al Mijan, Jeonga Lee, et al.
Natural Product Communications (2024) Vol. 19, Iss. 4
Open Access | Times Cited: 2
Deciphering the Effective Constituents and Mechanisms of Portulaca oleracea L. for Treating NASH via Integrating Bioinformatics Analysis and Experimental Pharmacology
Xiaoli He, Yiren Hu, Wei Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 10
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Ilias D. Vachliotis, Ioannis Valsamidis, Stergios A. Pοlyzos
Cancers (2023) Vol. 15, Iss. 21, pp. 5306-5306
Open Access | Times Cited: 5
Biosensor-based active ingredient recognition system for screening TNF-α inhibitors from lotus leaves
Jiawei Guan, Yu Xu, Yu Wei, et al.
Analytical and Bioanalytical Chemistry (2023) Vol. 415, Iss. 9, pp. 1641-1655
Closed Access | Times Cited: 4
The effects of chicory supplementation on liver enzymes and lipid profiles in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of clinical evidence
Elham Maleki, Ali Sadeghpour Tabaei, Erfan Taherifard, et al.
Clinical Nutrition ESPEN (2023) Vol. 55, pp. 447-454
Closed Access | Times Cited: 4
Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study
Ali Mahmoudi, Mohammad Mahdi Hajihasani, Muhammed Majeed, et al.
Current Genomics (2024) Vol. 25, Iss. 2, pp. 120-139
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top